Difference between revisions of "MEDICATION-ADRENALINE"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
| Line 4: | Line 4: | ||
==Reference(s)== | ==Reference(s)== | ||
Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council. | Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council. | ||
American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons. | <br/>American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons. | ||
[[Category:Medication]] | [[Category:Medication]] | ||
[[Category:Advanced Life Support]] | [[Category:Advanced Life Support]] | ||
Revision as of 01:50, 17 December 2022
1. Naturally occurring catecholamine with alpha (vasoconstriction) & beta effects.
2. Administer in the setting of cardiac arrest to cause vasoconstriction and to redirect available CO to the myocardium & brain.
3. It raises diastolic pressure thereby improving coronoary perfusion and facilitating defibrillation by improving myocardial blood flow during CPR.
4. Indications: asystole, PEA, pulseless VT/VF, bradycardia unresponsive to atropine.
5. Given IM in the setting of anaphylaxis: 0.5 mg every 15 min.
6. SE: tachycardia, HTN, arrhythmias, tissue necrosis if extravasation occurs, hyperglycaemia.
DOSAGE
7. Administer 1 mg every second loop of CPR (1:10,000 via IV cannula or 1:1000 via central line).
8. Infusion of 1-20 mcg/min in ICU.
Reference(s)
Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council.
American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons.
